GAIAbased

BUSINESS

Illimis secures funding for GAIA-based Alzheimer’s therapeutics

Illimis Therapeutics has completed a Series B funding round, securing $42m to expedite the development of its Gas6-mediated Anti-Inflammatory Adaptor…

Read More »
Back to top button